GeoVax Labs, a biotechnology company developing human vaccines using its novel platform technology, says Farshad Guirakhoo has joined the firm as Senior Vice President, Research and Development.
Guirakhoo is a world-renowned virologist and brings more than 20 years of experience in the development of vaccines and monoclonal antibody products to GeoVax. He is a former Executive/Senior Director of Sanofi Pasteur.
In his new role, Guirakhoo will play a leading role in the expansion of GeoVax's product development pipeline, and will be integral to collaborating on the development and implementation of a growth strategy to build upon GeoVax's novel platform technology and expertise. He will also contribute to the company's ongoing efforts to develop and commercialise its HIV and Ebola vaccines.
'We are thrilled that Dr Guirakhoo will be joining us,' said Harriet Robinson, Chief Scientific Officer at GeoVax.
'There is substantial work to be done to successfully move our current vaccine programmes forward and to build upon our technology platform; we are fortunate to have a professional of Dr Guirakhoo's calibre adding his talents to the effort.'
Dr Guirakhoo has held senior management and scientific roles within the biotechnology industry with Vaxess Technologies, Hookipa Biotech, Sanofi Pasteur, Acambis and OraVax.
